文献速递流行病学与生物统计医学教育与科研方法

对试验方案与结果发表中患者报告结局的元研究表明存在较大的结局报告偏倚

Metaresearch on patient-reported outcomes in trial protocols and results publications suggested large outcome reporting bias.
PubMed 文献 · J Clin Epidemiol · 2025-05-09

纳入瑞士、德国和加拿大伦理委员会2012年批准的237份及2016年批准的251份随机对照试验方案,系统检索对应结果发表与注册平台。488份方案中147份(30%)未报告使用患者报告结局(PRO),97份(20%)将PRO设为主要结局,另244份(50%)设为次要结局;预设PRO的341份方案中264份(77%)在8-10年后有结果可查,其中115/264(44%)报告了全部预设PRO,55/264(21%)未报告任何预设PRO,94/264(36%)报告了更多、更少或不同的PRO。结论认为存在结局报告偏倚且PRO报告质量常不足。

要点

  • 488份随机对照试验方案中147份(30%)未报告使用患者报告结局。
  • 预设PRO的341份方案中264份(77%)在8-10年后有结果发表或注册可查。
  • 有结果的264项试验中仅115项(44%)完整报告了方案预设的全部PRO。

核心结论

  • 预设PRO的随机对照试验方案中不足半数按方案预设报告了PRO,提示存在结局报告偏倚,且PRO报告质量常不足。
  • 这些局限使患者与医疗提供者之间的知情决策以及循证临床实践指南的制定变得复杂。

研究设计与样本

  • 纳入瑞士、德国和加拿大伦理委员会2012年批准的237份及2016年批准的251份随机对照试验方案。
  • 系统检索对应的同行评议结果发表和试验注册平台上的结果。
  • 由成对评审员独立提取方案特征、方案预设PRO及对应结果发表中报告的PRO。
  • 对以PRO为主要结局的随机对照试验,采用CONSORT-PRO扩展评估报告质量。

主要发现

  • 488份纳入方案中147份(30%)未报告使用PRO,97份(20%)将PRO设为主要结局,另244份(50%)设为次要结局。
  • PRO使用率在不同医学领域差异很大,从风湿病学和精神病学的100%到心脏病学和麻醉学的约三分之一。
  • 随机对照试验批准后8-10年,预设PRO的341份方案中264份(77%)有结果可查。
  • 有结果的264项发表试验中,115项(44%)报告了方案定义的全部PRO,55项(21%)未报告任何预设PRO,94项(36%)报告的PRO多于、少于或不同于预设。
  • 2012年和2016年批准方案间的这些发现一致;63篇以PRO为主要结局的同行评议随机对照试验发表中,13项CONSORT-PRO条目中有7项报告质量常不足。

关键数值与推荐

  • 488份随机对照试验方案中147份(30%)未报告使用PRO。
  • 341份预设PRO的方案中264份(77%)在8-10年后有结果可查。
  • 264项有结果的试验中115项(44%)报告全部预设PRO,55项(21%)未报告任何预设PRO,94项(36%)报告更多、更少或不同的PRO。
  • 63篇以PRO为主要结局的同行评议发表中,13项CONSORT-PRO条目有7项报告质量常不足。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patient-reported outcomes (PROs) provide crucial information for evaluating health-care interventions, but previous research in specific disease areas suggested infrequent use and incomplete reporting of PROs. We examined the prevalence and characteristics of PROs in randomized clinical trial (RCT) protocols across medical fields, their reporting quality, and the consistency between PROs specified in trial protocols and subsequent reporting in trial publications. STUDY DESIGN AND SETTING: We included 237 RCT protocols approved in 2012 and 251 approved in 2016, by ethics committees in Switzerland, Germany, and Canada. We systematically searched for corresponding peer-reviewed results publications and results on trial registries. Pairs of reviewers independently extracted characteristics of RCT protocols, PROs specified in protocols and reported in corresponding results publications, and assessed the reporting quality of RCTs with a PRO as the primary outcome using the Consolidated Standards of Reporting Trials-patient-reported outcome (CONSORTs-PRO) extension. RESULTS: Out of 488 included RCT protocols, 147 (30%) did not report use of a PRO; 97 (20%) specified a PRO as the primary outcome and an additional 244 (50%) as a secondary outcome. The prevalence of PROs varied substantially across medical fields, ranging from 100% in rheumatology and psychiatry to about one-third in cardiology and anesthesiology. At 8-10 years after RCT approval, results were available for 264 of the 341 (77%) trial protocols that prespecified PROs. Forty-four percent of the published trials (115/264) reported all PROs as defined in the protocol, 21% (55/264) did not report any prespecified PROs, and 36% (94/264) reported more, fewer, or different PROs than those prespecified. These findings were consistent between trial protocols approved in 2012 and 2016. Among 63 peer-reviewed RCT publications that reported a PRO as their primary outcome, reporting quality was often inadequate, with seven of 13 CONSORT-PRO items. CONCLUSION: Less than half of RCT protocols with planned PROs reported them as specified in corresponding published results, suggesting outcome reporting bias, and PRO reporting quality was often deficient. These limitations complicate informed decision-making between patients and health-care providers, as well as the development of evidence-based clinical practice guidelines.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Taji Heravi A, Gryaznov D, Busse JW, et al. Metaresearch on patient-reported outcomes in trial protocols and results publications suggested large outcome reporting bias. J Clin Epidemiol. 2025. PMID: 40349736. doi:10.1016/j.jclinepi.2025.111822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。